The Performance of a Target-Controlled Infusion of Propofol in Combination with Remifentanil: A Clinical Investigation with Two Propofol Formulations
- 1 February 2006
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 102 (2), 430-437
- https://doi.org/10.1213/01.ane.0000189821.81675.b4
Abstract
Target-controlled infusion (TCI) incorporates the pharmacokinetic variables of an IV drug to facilitate safe and reliable administration. In this clinical study we investigated the performance of propofol TCI in combination with remifentanil. Fifty-four adult patients scheduled for general surgery lasting longer than 1 h received a combined TCI of propofol (Marsh parameter set; propofol randomly either dissolved with long- or middle-/long-chain triglycerides) and remifentanil. Arterial propofol plasma concentrations and hemodynamic and derived electroencephalogram variables were determined at various stages before, during, and after surgery. Measured propofol plasma concentrations exceeded the predicted values by 59%, and 48% when recalculated with the Schnider parameter set. Pharmacokinetic population analysis showed a small central volume of distribution (3.55 L) and reduced clearance (1.31 L/min) for propofol. ASA status and sex were the only variables that had a significant influence on propofol pharmacokinetics. In a second step, a new pharmacokinetic variable set for propofol was determined in the first 27 patients. Post hoc performance analysis of the remaining 27 patients showed improved accuracy using the new variable set. Our results show that when remifentanil and propofol are combined, the Marsh and Schnider parameter sets systematically underestimate propofol plasma concentrations. Presented, in part, at the Annual Meeting of the European Society of Anesthesiologists, Amsterdam, The Netherlands, June 1, 1999, and the Annual Meeting of the American Society of Anesthesiologists, Dallas, Texas, October 12, 1999.Keywords
This publication has 28 references indexed in Scilit:
- Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery † †This article is accompanied by the Editorial.British Journal of Anaesthesia, 2003
- Non–steady State Analysis of the Pharmacokinetic Interaction between Propofol and RemifentanilAnesthesiology, 2002
- Remifentanil concentration during target-controlled infusion of propofol.Anaesthesia and Intensive Care, 2002
- Pharmacokinetics and Pharmacodynamics of RemifentanilAnesthesiology, 1997
- Pharmacokinetics of Propofol in Adult Patients Undergoing Coronary RevascularizationAnesthesiology, 1996
- Effects of Combining Propofol and Alfentanil on Ventilation, Analgesia, Sedation, and Emesis in Human VolunteersAnesthesiology, 1996
- Pharmacokinetic Model Selection for Target Controlled Infusions of PropofolAnesthesiology, 1995
- PHARMACOKINETIC MODEL DRIVEN INFUSION OF PROPOFOL IN CHILDRENBritish Journal of Anaesthesia, 1991
- STUDY OF THE POSSIBLE INTERACTION BETWEEN FENTANYL AND PROPOFOL USING A COMPUTER-CONTROLLED INFUSION OF PROPOFOLBritish Journal of Anaesthesia, 1990
- A general method for calculating the dosage scheme in linear pharmacokineticsEuropean Journal of Clinical Pharmacology, 1981